Chiara De‐Colle

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Solange Peters, Jean-Louis Pujol, Urania Dafni et al. · Annals of Oncology · 2021 · 105 citations · Full text

Oncology, Immune Checkpoint Inhibitor, Consolidation Nivolumab +6

Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effects

Marcel Nachbar, David Mönnich, Simon Boeke et al. · Radiotherapy and Oncology · 2019 · 77 citations

Engineering, Radiation Therapy, Medicine +10

Quality of life and fatigue before and after radiotherapy in breast cancer patients

Franziska Hauth, Chiara De‐Colle, N. Weidner et al. · Strahlentherapie und Onkologie · 2020 · 41 citations

Adaptive Radiotherapy, Quality Of Life, Radiation Therapy +8

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness

Apostolos Menegakis, Chiara De‐Colle, Ala Yaromina et al. · Radiotherapy and Oncology · 2015 · 38 citations · Full text

Radiation Exposure, Radiation Biology, Ex Vivo Irradiation +16

Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation

P Rovea, Alessandra Fozza, Pierfrancesco Franco et al. · Clinical Breast Cancer · 2015 · 36 citations

Radiation Medicine, Radiation Therapy, Daily 3-Week Hypofractionation +8